Amended Statement of Ownership (sc 13g/a)
February 13 2015 - 5:13PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
13G/A
Under the Securities Exchange Act of 1934
Amendment No. 6
SUCAMPO
PHARMACEUTICALS, INC.
(Name of Issuer)
CLASS A COMMON STOCK
(Title of Class of Securities)
864909106
(CUSIP Number)
DECEMBER 31, 2014
(Date of Event Which Requires Filing of this Statement)
Check the
appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule
13d-1(b)
¨ Rule 13d-1(c)
x Rule 13d-1(d)
Check the following box if a fee is being paid with this statement. ¨
|
|
|
|
|
|
|
(1) |
|
Name of
reporting person I.R.S. Identification No. of Above Person
S&R TECHNOLOGY HOLDINGS, LLC
52-2242847 |
(2) |
|
Check the appropriate box if a member
of a group (a) ¨ (b) ¨ |
(3) |
|
SEC use only
|
(4) |
|
Citizenship
DELAWARE |
Number of
shares beneficially
owned by each
reporting person
with |
|
(5) |
|
Sole voting power
21,460,802 |
|
(6) |
|
Shared voting power
0 |
|
(7) |
|
Sole dispositive power
21,460,802 |
|
(8) |
|
Shared dispositive power
0 |
(9) |
|
Aggregate amount beneficially owned by each reporting person
21,460,802 |
(10) |
|
Check box if the aggregate amount in
Row (9) excludes certain shares ¨ |
(11) |
|
Percent of class represented by amount
in Row (9) 48.4% |
(12) |
|
Type of reporting person
OO |
Item 1(a). |
Name of Issuer |
SUCAMPO PHARMACEUTICALS, INC.
Item 1(b). |
Address of Issuers Principal Executive Offices |
4520 EAST-WEST HIGHWAY
SUITE 300
BETHESDA,
MD 20814
Item 2(a). |
Name of Person Filing |
S&R TECHNOLOGY HOLDINGS, LLC
Item 2(b). |
Address of Principal Business Office or, if none, Residence |
7501 WISCONSIN AVENUE
SUITE 600E
BETHESDA,
MD 20814-6519
DELAWARE
Item 2(d). |
Title of Class of Securities |
CLASS A COMMON STOCK
864909106
Item 3. |
If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c): |
NOT
APPLICABLE
|
(a) |
Amount beneficially owned: |
21,460,802
48.4%
3
|
(c) |
Number of shares as to which the person has: |
|
(i) |
Sole power to vote or to direct the vote: |
21,460,802
|
(ii) |
Shared power to vote or to direct the vote: |
0
|
(iii) |
Sole power to dispose or to direct the disposition of: |
21,460,802
|
(iv) |
Shared power to dispose or to direct the disposition of: |
0
Item 5. |
Ownership of Five Percent or Less of a Class |
NOT APPLICABLE
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person |
NOT APPLICABLE
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person |
NOT APPLICABLE
Item 8. |
Identification and Classification of Members of the Group |
NOT APPLICABLE
Item 9. |
Notice of Dissolution of Group |
NOT APPLICABLE
NOT APPLICABLE
4
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
Dated: February 13, 2015 |
|
S&R TECHNOLOGY HOLDINGS, LLC |
|
|
|
|
|
By: |
|
/s/ Kei Tolliver |
|
|
Name: |
|
Kei Tolliver |
|
|
|
|
Executive Vice President |
5
Sucampo Pharmaceuticals, Inc. (delisted) (NASDAQ:SCMP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sucampo Pharmaceuticals, Inc. (delisted) (NASDAQ:SCMP)
Historical Stock Chart
From Sep 2023 to Sep 2024